18 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34730282 | Physiologically based pharmacokinetic modeling for dose optimization of quinine-phenobarbital coadministration in patients with cerebral malaria. | 2022 Jan | 1 |
2 | 26496779 | Clinical Pharmacology of Phenobarbital in Neonates: Effects, Metabolism and Pharmacokinetics. | 2016 | 1 |
3 | 23551241 | Phenobarbital-induced severe cutaneous adverse drug reactions are associated with CYP2C19*2 in Thai children. | 2013 May | 3 |
4 | 22331680 | Effects of cytochrome P450 (CYP)2C19 polymorphisms on pharmacokinetics of phenobarbital in neonates and infants with seizures. | 2012 Jun | 3 |
5 | 20509749 | Expression and inducibility by phenobarbital of CYP2C33, CYP2C42, CYP2C49, CYP2B22, and CYP3As in porcine liver, kidney, small intestine, and nasal tissues. | 2010 Aug | 1 |
6 | 27713373 | Update on the Genetic Polymorphisms of Drug-Metabolizing Enzymes in Antiepileptic Drug Therapy. | 2010 Aug 20 | 1 |
7 | 19702536 | The transcriptional regulation of the human CYP2C genes. | 2009 Jul | 2 |
8 | 17375979 | The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implications. | 2007 | 2 |
9 | 16789993 | Effect of CYP2C19 genetic polymorphism on pharmacokinetics of phenytoin and phenobarbital in Japanese epileptic patients using Non-linear Mixed Effects Model approach. | 2006 Jun | 8 |
10 | 15557548 | Pharmacogenetics and enzyme induction/inhibition properties of antiepileptic drugs. | 2004 Nov 23 | 1 |
11 | 11854139 | (+)-N-3-Benzyl-nirvanol and (-)-N-3-benzyl-phenobarbital: new potent and selective in vitro inhibitors of CYP2C19. | 2002 Mar | 1 |
12 | 12130704 | Expression and induction of CYP2C P450 enzymes in primary cultures of human hepatocytes. | 2002 Aug | 3 |
13 | 11181490 | Induction of CYP2C genes in human hepatocytes in primary culture. | 2001 Mar | 1 |
14 | 11294510 | P-hydroxylation of phenobarbital: relationship to (S)-mephenytoin hydroxylation (CYP2C19) polymorphism. | 2001 Apr | 2 |
15 | 10805060 | CYP2C19 polymorphism effect on phenobarbitone. Pharmacokinetics in Japanese patients with epilepsy: analysis by population pharmacokinetics. | 2000 Feb-Mar | 4 |
16 | 9314612 | Pharmacokinetic interactions with felbamate. In vitro-in vivo correlation. | 1997 Sep | 1 |
17 | 7554701 | Effects of felbamate on the pharmacokinetics of phenobarbital. | 1995 Sep | 1 |
18 | 1306117 | Induction of various cytochromes CYP2B, CYP2C and CYP3A by phenobarbitone in non-human primates. | 1992 Aug | 1 |